Cipro and Dipyrone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Dipyrone (metamizole). Common drug interactions include visual acuity reduced among females and acute hepatic failure among males.

The phase IV clinical study analyzes what interactions people have when they take Cipro and Dipyrone. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Dipyrone?

Dipyrone has active ingredients of metamizole. eHealthMe is studying from 1,876 Dipyrone users. Check the latest studies of Dipyrone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

13 people who take Cipro and Dipyrone together, and have interactions are studied.

Cipro and Dipyrone drug interactions.

What are the common drug interactions of Cipro and Dipyrone, by gender? *:

female:

  1. Visual acuity reduced (reduced clearness of vision)
  2. Weight increased
  3. Diarrhoea
  4. Weight decreased
  5. Abdominal pain
  6. Back pain
  7. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  8. Butterfly rash
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Chest pain

male:

  1. Acute hepatic failure
  2. Agitation (state of anxiety or nervous excitement)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Depressed level of consciousness
  5. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  6. Irritability
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Multi-organ failure (multisystem organ failure)
  9. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  10. Acute abdomen

What are the common drug interactions of Cipro and Dipyrone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Hypotension (abnormally low blood pressure)
  2. Immunosuppressant drug level decreased
  3. Neurological decompensation (inability of brain to maintain proper function)
  4. Nystagmus (a condition of involuntary eye movement)
  5. Partial seizures (seizures which affect only a part of the brain at onset)
  6. Respiratory disorder (respiratory disease)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Septic shock (shock due to blood infection)
  9. Vasculitis (inflammation of a blood vessel or blood vessels)
  10. Visual acuity reduced (reduced clearness of vision)

10-19:

n/a

20-29:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Abdominal pain
  3. Agitation (state of anxiety or nervous excitement)
  4. Anxiety
  5. Back pain
  6. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  7. Butterfly rash
  8. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  9. Chest pain
  10. Coma (state of unconsciousness lasting more than six hours)

30-39:

n/a

40-49:

n/a

50-59:

  1. Conjunctivitis (pink eye)
  2. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  3. Oral mucosal blistering (mouth ulcer)
  4. Pain
  5. Pruritus (severe itching of the skin)
  6. Pyrexia (fever)
  7. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

60+:

  1. Acute hepatic failure
  2. Cardiac failure acute
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Drug administration error
  5. Fall
  6. General physical condition
  7. Leukopenia (less number of white blood cells in blood)
  8. Nausea (feeling of having an urge to vomit)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Overdose

What are the existing conditions these people have? *

  1. Extravasation (leakage of a fluid): 2 people, 15.38%
  2. Breast Cancer: 1 person, 7.69%
  3. Abdominal Infection: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Dipyrone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cipro and Dipyrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dipyrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dipyrone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride and metamizole (the active ingredients of Cipro and Dipyrone, respectively), and Cipro and Dipyrone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: